| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.87B | +24.6% |
| Gross profit | ¥0.35B | — |
| Operating income | ¥0.16B | — |
| Net income | ¥0.14B | +12.5% |
| Gross margin | 39.6% | Net margin 16.0% |
| Revenue Q/Q | -1.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.53B | 60.4% |
| R&D | ¥0.05B | 5.2% |
| SG&A | ¥0.12B | 13.3% |
| Tax & other | ¥0.02B | 2.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
天利科技 ・ 劲拓股份 ・ 花园生物 ・ 宝色股份 ・ 汉宇集团 ・ 博济医药 ・ 科隆股份 ・ 九强生物 ・ 凯发电气 ・ 道氏技术 ・ 正业科技 ・ 金盾股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies